Home » ETF » LABD

LABD - Direxion Daily S&P Biotech Bear 3x Shares

Stock Price: $24.95 USD 0.15 (0.60%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
Assets $63.94M
NAV $24.92
Expense Ratio 1.06%
PE Ratio n/a
Beta (5Y) -3.07
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Mar 24, 2020
1-Year Return -
Trading Day April 20
Last Price $24.95
Previous Close $24.80
Change ($) 0.15
Change (%) 0.60%
Day's Open 25.17
Day's Range 24.00 - 26.47
Day's Volume 3,251,432
52-Week Range 12.30 - 157.20

Fund Description

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Asset Class
Portfolio-Multi Asset
Sector
Biotech
Region
Global
Inception Date
May 28, 2015
Exchange
NYSEARCA
Ticker Symbol
LABD
Index Tracked
S&P Biotechnology Select Industry Index

Dividends

Ex-DividendAmountPay Date
Mar 24, 2020$0.995Mar 31, 2020
Dec 23, 2019$0.014Dec 31, 2019
Sep 24, 2019$0.059Oct 1, 2019
Jun 25, 2019$0.087Jul 2, 2019
Mar 19, 2019$0.056Mar 26, 2019
Dec 27, 2018$0.191Jan 4, 2019
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

The last week was extremely upbeat for Wall Street with the S&P 500 and the Dow Jones at record highs.

Other tickers mentioned: DRIP, FNGU, GDXU, NRGD, TECL, WANT
1 week ago - Zacks Investment Research

Amid the bull and bear tug-of-war, the demand for leveraged and inverse-leveraged ETFs has increased.

Other tickers mentioned: CLDS, DUSL, NAIL, RETL, TPOR, UTSL
3 weeks ago - Zacks Investment Research

Last week was mixed for Wall Street. Tax hike fears, rising COVID-19 cases and still-existing rising rate worries led to the volatility.

Other tickers mentioned: BZQ, FNGD, JDST, NAIL
3 weeks ago - Zacks Investment Research

The S&P 500 Biotech index rose as much as 25% last year after falling as low as 8% during the apex of last year's sell-offs. Now, downward pressure is helping leveraged inverse funds like the Direxion D...

1 month ago - ETF Trends

The first week of March was mixed for Wall Street. The energy sector has been the key winner.

Other tickers mentioned: CLDS, DPST, GUSH, JNJ, NRGU, USO, WEBS
1 month ago - Zacks Investment Research

Wall Street crashed last week with the S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 losing about 2.5%, 1.8%, 4.9% and 2.4%, respectively.

Other tickers mentioned: BZQ, EDZ, FNGD, YANG
1 month ago - Zacks Investment Research

Wall Street saw a mixed performance last week probably because of rising COVID-19 cases globally while a stimulus deal cheered up the market.

Other tickers mentioned: CHAU, KORU, SOXL, UTSL
3 months ago - Zacks Investment Research

The COVID-19 pandemic put biotech in the spotlight as companies around the globe worked feverishly to create a vaccine. Once a tried-and-true vaccine is developed and subsequently incorporated as standa...

4 months ago - ETF Trends

It's not just stocks that are made for shorting. Plenty of traders tap exchange-traded funds on the bearish side of things and do so for a variety of reasons.

Other tickers mentioned: EDZ
11 months ago - Benzinga

The biotech and healthcare space has been on fire lately. The healthcare space is witnessing a Mergers and Acquisitions wave recently that has achieved an impressive $342 billion in new deal activity so...

Other tickers mentioned: LABU
1 year ago - ETF Trends

We have highlighted six leveraged inverse ETFs that are up more than 15% over the past week.

Other tickers mentioned: DRIP, DUG, ERY, GASX
1 year ago - Zacks Investment Research

The U.S.-China trade war is more than 18 months old. And in that time the conflict has taken a toll on stocks across the world and put company executives and market watchers alike on edge.

Other tickers mentioned: SOXL, SOXS, LABU, TECL, TECS
1 year ago - Benzinga